Challenges in diagnosis and biomarker testing for RET-altered lung and thyroid cancer care: an international mixed-method study

BACKGROUND: The introduction of new targeted therapies for RET-altered lung and thyroid cancers (LC/TC) has impacted pathologists’ practice by making genomic testing more relevant. Variations in health systems and treatment access result in distinct clinical challenges and barriers. This study aimed...

Descripción completa

Detalles Bibliográficos
Autores principales: Lazure, Patrice, Sireci, Anthony, Subbiah, Vivek, Murray, Suzanne, Grohé, Christian, Sherman, Steven I., Kelly, Elizabeth, Bubach, Patrick, Péloquin, Sophie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241144/
https://www.ncbi.nlm.nih.gov/pubmed/37277734
http://dx.doi.org/10.1186/s12909-023-04396-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241144/
https://www.ncbi.nlm.nih.gov/pubmed/37277734
http://dx.doi.org/10.1186/s12909-023-04396-w

Ejemplares similares